Vice President, Global Regulatory Affairs

Embark on an enriching journey with PROCEPT BioRobotics, where our vision, mission, and values guide everything we do as a company. We are committed to revolutionizing treatment for benign prostatic hyperplasia (BPH, otherwise known as prostate gland enlargement) through innovation in surgical robotics. As our company succeeds and grows, we improve the quality of life of patients, provide more effective treatment options for surgeons, uphold the trust of our shareholders. That starts with a commitment to our People with a focus on creating an evolving landscape for your career, brimming with transformative opportunities that provide continuous career growth opportunities.

As PROCEPT BioRobotics’ continues to evolve and expand its global footprint, we seek a world-class regulatory executive to serve as Vice President (VP) of Global Regulatory Affairs (RA). This role will report into the SVP of Global RAQA. This leader will architect and execute a forward-looking, comprehensive regulatory strategy supporting PROCEPT BioRobotics’ complex surgical robotics portfolio—including oncology applications such as prostate cancer—and other emerging technologies. The successful candidate has a proven track record guiding diverse, cross-functional teams to regulatory success in multiple global jurisdictions, while fostering a culture of compliance, agility, and innovation.

This role will assume full responsibility for both strategic and operational RA initiatives—driving regulatory submissions and approvals, cutting edge regulatory intelligence, global market entry, and post-market compliance. The ideal candidate has at least two years of prior VP-level experience, excels at on-boarding different or emerging technologies, and possesses excellent writing skills and robust knowledge of clinical, hardware, and software components. Experience with complex product categories, including software releases including artificial intelligence/machine language (AI/ML) functions, oncology-focused submissions (e.g., prostate cancer) and PMA-level submissions in surgical robotics, is highly desired.